(2-Methyl-1,3-thiazol-5-yl)methanamine
Grundinformationen
- CAS
63139-97-9- Standard-SMILES
Cc1ncc(CN)s1- InChIKey
XYRSJQNUWZHRBX-UHFFFAOYSA-N- Summenformel
- C5H8N2S
- Durchschnittliche Molmasse
- 128,2 g/mol
- Monoisotopische Masse
- 128,04081944
Namen und Bezeichner
- Bevorzugter Name
- (2-Methyl-1,3-thiazol-5-yl)methanamine
- IUPAC
- (2-methyl-1,3-thiazol-5-yl)methanamine
- Englischer Name
- (2-Methyl-1,3-thiazol-5-yl)methylamine
- Summenformel
- C5H8N2S
- Molmasse
- 128.2
Namen und Synonyme
(2-methyl-1,3-thiazol-5-yl)methanamineRefChem:396037820-109-4(2-methylthiazol-5-yl)methanamine63139-97-9C-(2-Methyl-thiazol-5-yl)-methylamine5-(aminomethyl)-2-methylthiazoleMFCD028536145-Thiazolemethanamine, 2-methyl-(2-METHYL-1,3-THIAZOL-5-YL)METHYLAMINESCHEMBL243107DTXSID20597689
Weitere Namen anzeigen
(2-methylthiazole-5-yl)methylamine
BS-12866CS-0113081F14010XYRSJQNUWZHRBX1-(2-Methyl-1,3-thiazol-5-yl)methanamineA902007SCHEMBL3695252XYRSJQNUWZHRBX-UHFFFAOYSA-N
Datenbank-Bezeichner
- CAS
63139-97-9- PubChem CID
- 19046689
- DTXSID
DTXSID20597689- EC Number
- 820-109-4
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 0,2
- Polarare Oberfläche (TPSA)
- 67,2 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 8
- Formalladung
- 0
- Komplexität
- 76
Physikochemische Eigenschaften
- Siedepunkt
- 221.4 · 221.4±15.0 °C(Predicted)
- Dichte
- 1.182 · 1.182±0.06 g/cm3(Predicted)
- storage temp.
- 2 · under inert gas (nitrogen or Argon) at 2–8 °C
- pka
- 8.26 · 8.26±0.29(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral];H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 3 (100%);Skin Irrit. 2 (100%);Eye Dam. 1 (100%);STOT SE 3 (100%)
Sicherheitsdaten
- risk_code
- 22-37/38-41
- hazard_code
- Xn
- safety_code
- 26-39
Chemie und Industrie
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Anbieter30 Anbieter
上海康恩博医药科技有限公司17510465506 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
杭州摩库生物医药科技有限公司+86-057181025280; +8617767106207 · [email protected]
上海爱孜康医药研究有限公司18721109360 · [email protected]
上海冬洋生物科技有限公司0512-13601744364 13601744364
Compound Net Biotechnology Inc.15266686121 · [email protected]
Aladdin Scientific[email protected]
南京腾怡生物科技有限公司17714337195 · [email protected]
郑州药领医药科技有限公司13526569071 · [email protected]
天津林宸科技有限公司15122256084 15122256084 · [email protected]
苏州岚云医药科技有限公司2332782371 · [email protected]
赛纳斯特化学(欢迎点击联系)021-60343070
上海安米克化学品有限公司微信 17321281695 18019252918 · [email protected]
上海威芬奇医药科技有限公司13817485796 · [email protected]
盐城希曼生物科技有限公司0515-88280676; 18921872653
上海卡洛化学有限公司21-33526724 18930996265 · [email protected]
深圳市创鑫生物科技有限公司13417589054 · [email protected]
南京博米尔生物科技有限公司025-83453382-8005 · [email protected]
上海超岚化工科技中心QQ:65489617 13301690235 · [email protected]
上海晶石医药科技有限公司021-000000 · [email protected]
上海智乾生物科技有限公司[email protected]
江苏艾康生物医药研发有限公司025-58859352 17714375163 · [email protected]
深圳市创鑫生物科技有限公司13417589054 · [email protected]
上海杰瑞兴生物医药科技有限公司17521512546 17721492509 · [email protected]
上海凯为化学科技有限公司021-58461859 15821823057 · [email protected]
上海皓鸿生物医药科技有限公司400-8210725 4008210725 · [email protected]
佰美济华(河南)医药科技有限公司0371-88900765 18037465274 · [email protected]
上海捷世凯生物科技有限公司021-57520305 13795461237 · [email protected]
南京一览生物科技有限公司13851808754 · [email protected]
江西优垦生物科技有限公司15107073929 · [email protected]
Zugehörige Reaktionen
8
Notizen zur Verbindung
Wird geladen…